Vimarsana
Biggest News Aggregation in the World

Phasei Clinical Trials Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phasei Clinical Trials Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phasei Clinical Trials Program Today - Breaking & Trending Today

LoRusso named the Amy and Joseph Perella Professor of Medicine - Vimarsana News

LoRusso named the Amy and Joseph Perella Professor of Medicine

Patricia LoRusso is an internationally recognized expert in drug development and early-phase clinical investigation of novel cancer therapies.

Source: yale.edu
Local doctor among authors of oncology group call-to-action - Vimarsana News

Local doctor among authors of oncology group call-to-action

A new call-to-action published January 9 in the journal Cancer details practical steps for the oncology research and clinical care communities to

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team - Vimarsana News

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team

/PRNewswire/ -- Shasqi, Inc. ("Shasqi") a clinical stage biotech company, whose mission is to revolutionize cancer treatment with click chemistry, today...

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team - Vimarsana News

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team

SAN FRANCISCO, Aug. 2, 2023 /PRNewswire/ -- Shasqi, Inc. ('Shasqi') a clinical stage biotech company, whose mission is to revolutionize cancer tre...

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA - Vimarsana News

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation...